Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
4.60
0.21 (4.78%)
At close: Jun 24, 2025, 3:59 PM
4.64
0.87%
After-hours: Jun 24, 2025, 04:00 PM EDT
4.78% (1D)
| Bid | 4.15 |
| Market Cap | 5.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -12.14 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 4.8 |
| Volume | 14,234 |
| Avg. Volume (20D) | 24,853 |
| Open | 4.32 |
| Previous Close | 4.39 |
| Day's Range | 4.32 - 5.01 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.84 |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
3 weeks ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.